Invenia's annual revenue declined for four straight years, from KRW 56.9 billion in 2022 to KRW 22.7 billion in 2023, KRW 21.8 billion in 2024, and KRW 18.4 billion in 2025.
Over the same period, operating losses were KRW 12.7 billion, KRW 14.1 billion, KRW 10.9 billion, and KRW 8.6 billion respectively, with the 2025 operating margin still deeply negative at -46.7%.
Net income attributable to owners widened from a loss of KRW 1.0 billion in 2022 to a loss of KRW 17.5 billion in 2023, before narrowing slightly to losses of KRW 10.0 billion in 2024 and KRW 12.7 billion in 2025.
Equity fell from KRW 52.5 billion in 2022 to KRW 15.7 billion in 2025, while the debt ratio rose sharply from 116.7% to 323.5% over the same span, indicating a weakened capital buffer.
On a quarterly basis, revenue shrank to just KRW 1.26 billion in Q3 2025 with an operating loss of KRW 3.22 billion, before rising to KRW 11.87 billion in Q4 2025 as the operating loss narrowed to KRW 2.20 billion.
In Q1 2026, revenue jumped to KRW 14.01 billion with an operating profit of KRW 0.19 billion and net profit of KRW 2.21 billion, marking a break from the long loss streak that appears tied to recognition of a large order contract.
However, Q2 2026 revenue fell back to about KRW 2.62 billion with an operating loss of KRW 2.65 billion and a net loss of KRW 2.77 billion, suggesting the Q1 turnaround was closer to a one-off event.
This quarter-to-quarter swing reflects a structural feature in which results hinge heavily on the timing of revenue recognition from a small number of large contracts.
Annual operating cash flow turned slightly positive at KRW 0.59 billion in 2025, a break from cash outflows in 2023 and 2024, though it remains premature to view this as a fundamental sign of earnings recovery.